Beijing Sun-Novo Pharmaceutical Research Co., Ltd. (SHA:688621)

China · Delayed Price · Currency is CNY

70.22

+1.22 (1.77%)

Sep 10, 2026, 1:44 PM CST

Market Cap	7.54B -13.2%
Revenue (ttm)	1.06B -4.3%
Net Income	49.63M -68.7%
EPS	0.45 -68.3%
Shares Out	109.28M
PE Ratio	152.98
Forward PE	n/a
Dividend	0.19 (0.26%)
Ex-Dividend Date	Jun 29, 2026

Volume	1,466,960
Open	68.88
Previous Close	69.00
Day's Range	68.08 - 70.65
52-Week Range	46.68 - 85.95
Beta	-0.11
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 29, 2026

About SHA:688621

Beijing Sun-Novo Pharmaceutical Research Co., Ltd., a contract research company, engages in the research and development of drugs in China. The company operates an external preparation platform that focuses on the research and development of new drugs and generic drugs for skin external preparations; children's clinical data bridging research center; pediatric drug research and development platform; pediatric drug delivery dosage research and development platform; oncology, metabolic diseases, respiratory tract drug delivery and topical prepara... [Read more]

Industry Drug Manufacturers - Specialty & Generic

Sector Healthcare

Founded 2009

Employees 1,335

Stock Exchange Shanghai Stock Exchange

Ticker Symbol 688621

Full Company Profile

Financial Performance

In 2025, SHA:688621's revenue was 1.22 billion, an increase of 13.33% compared to the previous year's 1.08 billion. Earnings were 203.87 million, an increase of 14.91%.

Financial Statements